Breast Cancer Pill & Co-Q-10 Studies

[Guest guest]

This article was published on November 24, 2008 in New Star. I tried to access

it today and it was not available unless I signed up to become a member. If you

want the entire article, I may be able to send it to you privately, through my

file copy. I know there are some members in this group who have had breast

cancer and one who is currently fighting both breast cancer and CML; therefore I

thought there might be an interest in the group by some. Who among us doesn't

know someone who hasn't been affected by breast cancer? Anyone interested in

the trial could contact the pharmacologist to get more details.

The University of Louisiana at Monroe pharmacologist, Sylvester has done

research on the benefits of vitamin E in cancer. Through his research, he

believes they are on the verge of a major breakthrough in breast cancer

prevention. The main ingredient found in Vitamin E is tocotrienois, which he

has put his focus on. Sylvester believes that these treatments could inhibit

many types of tumors; that it would work on every kind of cell. This in

particular caught my eye.

Human trials are scheduled to begin in January. A commercial product could be

marketed in as little as 3 to 5 years. This product being a natural food, would

not have to be approved by the FDA; however the agency has been cracking down on

claims that vitamin companies often claim as cures. Beta Pharma of Australia is

funding the research, so this is not some run of the mill hoax cooked up to sell

vitamins. When the data is in, it will probably have to be approved by the FDA

because of it's claims. My first CML trial was a high concentration of Vitamin

A, so I would envision that the tocotrienois would go through the same channels

to obtain approval. I first saw the article in my local newspaper, but it was

not available for reprint, so I tracked down the author to get the original

information.

_____________________________________________________

Randomized studies by National Cancer Institute on CoQ10. The entire article on

the studies can be found at the tinyurl below:

Have any clinical trials (research studies with people) of coenzyme Q10 been

conducted?

There have been no well-designed clinical trials involving large numbers of

patients to study the use of coenzyme Q10 in cancer treatment. There have been

some clinical trials with small numbers of people, but the way the studies were

done and the amount of information reported made it unclear if benefits were

caused by the coenzyme Q10 or by something else. Most of the trials were not

randomized or controlled. Randomized controlled trials give the highest level of

evidence:

a.. In randomized trials, volunteers are assigned randomly (by chance) to one

of 2 or more groups that compare different factors related to the treatment.

b.. In controlled trials, one group (called the control group) does not

receive the new treatment being studied. The control group is then compared to

the groups that receive the new treatment, to see if the new treatment makes a

difference.

c..

d.. http://tinyurl.com/6kvoy5

FYI,

Lottie

[Guest guest]

This is a good article, glad your educating the rest!

Dory Doggie

________________________________

From: Lottie Duthu <lotajam@...>

CML < >

Sent: Saturday, December 6, 2008 3:09:06 AM

Subject: [ ] Breast Cancer Pill & Co-Q-10 Studies

This article was published on November 24, 2008 in New Star. I tried to access

it today and it was not available unless I signed up to become a member. If you

want the entire article, I may be able to send it to you privately, through my

file copy. I know there are some members in this group who have had breast

cancer and one who is currently fighting both breast cancer and CML; therefore I

thought there might be an interest in the group by some. Who among us doesn't

know someone who hasn't been affected by breast cancer? Anyone interested in

the trial could contact the pharmacologist to get more details.

The University of Louisiana at Monroe pharmacologist, Sylvester has done

research on the benefits of vitamin E in cancer. Through his research, he

believes they are on the verge of a major breakthrough in breast cancer

prevention. The main ingredient found in Vitamin E is tocotrienois, which he

has put his focus on. Sylvester believes that these treatments could inhibit

many types of tumors; that it would work on every kind of cell. This in

particular caught my eye.

Human trials are scheduled to begin in January. A commercial product could be

marketed in as little as 3 to 5 years. This product being a natural food, would

not have to be approved by the FDA; however the agency has been cracking down on

claims that vitamin companies often claim as cures. Beta Pharma of Australia is

funding the research, so this is not some run of the mill hoax cooked up to sell

vitamins. When the data is in, it will probably have to be approved by the FDA

because of it's claims. My first CML trial was a high concentration of Vitamin

A, so I would envision that the tocotrienois would go through the same channels

to obtain approval. I first saw the article in my local newspaper, but it was

not available for reprint, so I tracked down the author to get the original

information.

____________ _________ _________ _________ _________ _____

Randomized studies by National Cancer Institute on CoQ10. The entire article on

the studies can be found at the tinyurl below:

Have any clinical trials (research studies with people) of coenzyme Q10 been

conducted?

There have been no well-designed clinical trials involving large numbers of

patients to study the use of coenzyme Q10 in cancer treatment. There have been

some clinical trials with small numbers of people, but the way the studies were

done and the amount of information reported made it unclear if benefits were

caused by the coenzyme Q10 or by something else. Most of the trials were not

randomized or controlled. Randomized controlled trials give the highest level of

evidence:

a.. In randomized trials, volunteers are assigned randomly (by chance) to one of

2 or more groups that compare different factors related to the treatment.

b.. In controlled trials, one group (called the control group) does not receive

the new treatment being studied. The control group is then compared to the

groups that receive the new treatment, to see if the new treatment makes a

difference.

c..

d.. http://tinyurl. com/6kvoy5

FYI,

Lottie